Press Releases
GSK seeks European approval for eltrombopag to treat severe aplastic anaemia
British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). ...
Press Releases
New Oncology to Collaborate with National Cancer Centre Singapore on Genetic Testing
Cologne, Germany, November 12, 2014 / B3C newswire / -New Oncology announced today that it has entered into a collaboration with the National Cancer Centre...
Press Releases
New Management Organisation of the Haselmeier Group
Zurich, Switzerland, November 10, 2014 / B3C newswire / - Haselmeier was able to successfully grow over the past few years, allowing the company to...
Press Releases
Novasep and partner Nilsan Nishotech to install the first continuous chromatography system at Laurus Labs
Novasep Varicol high-performance continuous chromatography technology brings productivity gains in an Indian-based API commercial production Novasep, a leading supplier of manufacturing solutions...
Press Releases
TxCell to present at EU Advanced Therapies Investor Day November 13, in London, UK
Valbonne, France, November 7, 2014. – TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific...
Press Releases
TxCell reports revenues for the third quarter of 2014
TxCell (FR0010127662 - TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory...
Press Releases
CARLINA Technologies signs a partnership agreement with GenBiotech to develop a sustained-release protein formulation for cartilage repair
CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.